Rifaximin: Difference between revisions

(annotation)
(Text replacement - "Category:Drugs" to "Category:Pharmacology")
Line 51: Line 51:
==References==
==References==
<Epocrates, UpToDate>
<Epocrates, UpToDate>
[[Category:Drugs]]
[[Category:Pharmacology]]

Revision as of 15:53, 22 March 2016

Administration

  • Type: Antibiotic
  • Dosage Forms: 200, 550
  • Routes of Administration: Oral
  • Common Trade Names: Xifaxan

Adult Dosing

  • Traveler's diarrhea, E. coli-induced: 200 mg PO tid x3 days
  • Hepatic encephalopathy: 550 mg PO bid
  • IBS, diarrhea-predominant: 550 mg PO tid x14 days
    • May repeat dose up to 2x if recurrent dz

Pediatric Dosing

For > 12 yrs old

  • Traveler's diarrhea, E. coli-induced: 200 mg PO tid x3 days

Special Populations

Renal Dosing

  • No adjustment

Hepatic Dosing

  • No adjustment

Contraindications

  • Allergy to class/drug
  • caution if hepatic impairment (Child-Pugh Class C)
  • caution if recent abx-associated colitis

Adverse Reactions

Serious

  • superinfection
  • C. difficile-assoc. diarrhea
  • hypersensitivity rxn
  • angioedema
  • anaphylaxis
  • exfoliative dermatitis

Common

  • peripheral edema
  • nausea
  • dizziness
  • fatigue

Comments

See Also

References

<Epocrates, UpToDate>